z-logo
Premium
The ND2 subunit is labeled by a photoaffinity analogue of asimicin, a potent complex I inhibitor
Author(s) -
Nakamaru-Ogiso Eiko,
Han Hongna,
Matsuno-Yagi Akemi,
Keinan Ehud,
Sinha Subhash C.,
Yagi Takao,
Ohnishi Tomoko
Publication year - 2010
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2010.01.004
Subject(s) - submitochondrial particle , photoaffinity labeling , chemistry , benzophenone , inhibitor protein , rotenone , protein subunit , oxidative phosphorylation , stereochemistry , anthraquinones , quinone , electron transport complex i , affinity label , oxidoreductase , nadh dehydrogenase , biochemistry , mitochondrion , enzyme , binding site , biology , photochemistry , botany , gene
NADH:ubiquinone oxidoreductase (complex I) is the entry enzyme of mitochondrial oxidative phosphorylation. To obtain the structural information on inhibitor/quinone binding sites, we synthesized [ 3 H]benzophenone‐asimicin ([ 3 H]BPA), a photoaffinity analogue of asimicin, which belongs to the acetogenin family known as the most potent complex I inhibitor. We found that [ 3 H]BPA was photo‐crosslinked to ND2, ND1 and ND5 subunits, by the three dimensional separation (blue‐native/doubled SDS–PAGE) of [ 3 H]BPA‐treated bovine heart submitochondrial particles. The cross‐linking was blocked by rotenone. This is the first finding that ND2 was photo‐crosslinked with a potent complex I inhibitor, suggesting its involvement in the inhibitor/quinone‐binding.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom